Anavex Life Sciences Corp (AVXL)

[Steady_T]

Here are some details on the deal that Prilenia entered into for its P2 drug. I would hope that Anavex wouldn't enter into a deal anywhere close to these terms.

Under the terms of the agreement, Prilenia will receive an upfront payment of approximately €80 million plus up to €45 million in near-term development, regulatory, and commercial milestones. The total deal is valued at up to approximately €500 million in upfront and total milestone payments. In addition, Prilenia will receive tiered double-digit royalties on net sales. Prilenia and Ferrer have agreed to jointly develop and fund the expansion of pridopidine in the territory for additional indications beyond HD. Prilenia will retain full rights to pridopidine in other major markets, including North America, Japan and Asia Pacific.

Anavex shouldn't enter in to any marketing deal until 2-73 is approved. And, the terms should be many times more favorable to Anavex than the deal that Prilenia entered into. Missling has managed the finances so that any agreements will be on very much better terms.